Calyxt Inc (NASDAQ:CLXT)’s share price traded up 5.4% on Thursday . The stock traded as high as $12.95 and last traded at $12.90. 100,422 shares traded hands during mid-day trading, an increase of 71% from the average session volume of 58,874 shares. The stock had previously closed at $12.24.
Several analysts have weighed in on the stock. National Securities reiterated a “buy” rating and issued a $35.00 price objective on shares of Calyxt in a research note on Thursday. BidaskClub cut shares of Calyxt from a “sell” rating to a “strong sell” rating in a research note on Thursday, June 13th. Finally, Zacks Investment Research upgraded shares of Calyxt from a “hold” rating to a “buy” rating and set a $17.00 price objective for the company in a research note on Tuesday, May 14th. One analyst has rated the stock with a sell rating, one has given a hold rating and five have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $22.60.
The company has a current ratio of 18.72, a quick ratio of 18.63 and a debt-to-equity ratio of 0.21. The stock has a 50 day moving average price of $13.76. The firm has a market cap of $408.10 million, a price-to-earnings ratio of -13.71 and a beta of 2.67.
In other news, CEO James Blome sold 2,582 shares of the business’s stock in a transaction that occurred on Tuesday, April 2nd. The shares were sold at an average price of $16.65, for a total value of $42,990.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Manoj Sahoo sold 1,522 shares of the business’s stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $17.33, for a total transaction of $26,376.26. The disclosure for this sale can be found here. Insiders sold a total of 7,854 shares of company stock valued at $130,529 in the last quarter. Corporate insiders own 2.30% of the company’s stock.
Several large investors have recently modified their holdings of CLXT. Vanguard Group Inc. grew its position in Calyxt by 2.0% during the 3rd quarter. Vanguard Group Inc. now owns 377,640 shares of the company’s stock worth $5,766,000 after purchasing an additional 7,246 shares in the last quarter. California Public Employees Retirement System grew its position in Calyxt by 17.0% during the 4th quarter. California Public Employees Retirement System now owns 11,700 shares of the company’s stock worth $121,000 after purchasing an additional 1,700 shares in the last quarter. Bank of New York Mellon Corp grew its position in Calyxt by 33.1% during the 4th quarter. Bank of New York Mellon Corp now owns 21,447 shares of the company’s stock worth $222,000 after purchasing an additional 5,336 shares in the last quarter. Tibra Equities Europe Ltd purchased a new position in Calyxt during the 4th quarter worth approximately $232,000. Finally, RMB Capital Management LLC purchased a new position in Calyxt during the 4th quarter worth approximately $857,000. Institutional investors own 28.30% of the company’s stock.
Calyxt Company Profile (NASDAQ:CLXT)
Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for agriculture in the United States. It engages in the development of high oleic and low linolenic soybean product candidates; high fiber wheat; improved quality alfalfa product candidates; and cold storable and reduced browning potatoes.
Recommended Story: Commodities
Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.